In type 2 diabetes, saxagliptin increased HF hospitalizations, regardless of history of HF or CKD

Danae A. Delivanis, Victor M. Montori

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'In type 2 diabetes, saxagliptin increased HF hospitalizations, regardless of history of HF or CKD'. Together they form a unique fingerprint.